title: Keynote comment: reimbursement for molecularly targeted anticancer agents.
authors.forename: Umberto
authors.initials: U
authors.lastname: Tirelli
authors.forename: Gilberto
authors.initials: G
authors.lastname: de Castro
authors.forename: Ahmad
authors.initials: A
authors.lastname: Awada
mesh_terms: D000970:Antineoplastic Agents / Q000191:economics / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D017277:Drug Approval; D016527:Drug Costs; D017850:Economics, Pharmaceutical; D052138:Genes, Neoplasm; D006801:Humans; D007349:Insurance, Health, Reimbursement; D008967:Molecular Biology; D009369:Neoplasms / Q000188:drug therapy* / Q000235:genetics* / Q000503:physiopathology
chemical_list: D000970:Antineoplastic Agents